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New Initiatives at The Rockefeller University 
In fulfillment of its mandate for excellence and cogency in research, The 
Rockefeller University has launched a set of new initiatives in fields of 
biochemistry and molecular biology, which encompass genetics, cell 
biology, and neurobiology. 
These revolutionary frontiers for biological and medical science 
relate to problems of cancer, reproduction, food supply, brain science, 
mental disease, genetic abnormalities, and many degenerative disorders 
caused by agents ranging from viruses to parasites. The research under­
taken will augment worldwide progress in agriculture, medicine, and 
public health. 
Seven new research laboratories are being established in the brief 
period between r 98 r and r 98 3. Appointment of the extraordinarily tal­
ented leaders of these new laboratories, along with their many gifted 
young colleagues, constitutes the most important surge of first-rank 
investigators onto the campus during the past 20 years. The opportunity 
for this surge stems in part from the retirement or death of some of the 
University's most notable figures. As always, new laboratories call for 
new levels of material commitment even at a time when the University 
as a whole is under a stringent discipline in its growth. 
To supplement available private and public support, the University 
needs $ 3 5 million over the next two years to underwrite new initiatives 
in these fields. This funding would endow professorships, support part 
of the new and ongoing program for young investigators, and help meet 
the cost of urgent modernization of research facilities and equipment. 
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Molecular Biology-the New Frontier 
To understand the emerging revolutionary opportunities in biology and 
medicine, which are central to the University's New Initiatives, it is 
important to grasp the overall perspectives of molecular biology. This 
modern science is organized around the principle that, in order to 
understand the complexities of living organisms, it is necessary to 
understand the very basic constituents-molecules-which form cells 
and, in turn, structure tissues and entire organisms. Investigations at 
the molecular level are aimed at the fundamental building blocks of life. 
These are, in themselves, complex biochemical structures. 
Molecular biology emerged from the successful research by many 
laboratories in biochemistry and genetics in the late 1930s and r 940s. 
Perhaps the most notable landmark came from The Rockefeller Insti­
tute, with the discovery in r 944 by A very, Macleod, and McCarty that 
the chemical basis of heredity is DNA. The seminal quality of the molec­
ular approach was deepened in 1953 with Watson and Crick's picture of 
the double-helix structure of DNA.
The double-helix DNA comprises two long thin chains twisted about 
each other in a regular manner, like a double spiral staircase. Each chain 
is built of smaller units (called nucleotides) that are cross-connected by a 
"lock-and-key" pairing of single units on each chain. The overall 
sequence of the units in a chain constitutes the genetic code. 
The fundamental "words" of the genetic code were found to be 
groupings of three nucleotides. These "code words" pass their instruc­
tions first to so-called messenger RNA molecules and then to the key 
building blocks (amino acids) in the cell. They direct the amino acids to 
line up and combine in a particular sequence, forming specific proteins 
of the cell in a unique order. This specific sequencing is what makes, for 
example, the protein in our hair-coded by one gene-different from the 
protein in our red blood cells, coded by another gene. 
A ware that the sequence of nucleotides is the code that determines 
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ultimately the character of genetic material, and by using procedures to 
move genes around, investigators discovered a new picture. This picture 
revealed more about the, detailed structure of genes and the elements 
controlling their functions. 
Later, when a way to synthesize proteins in the laboratory was dis­
covered, the path to determining the genetic code was opened. Subse­
quently, the precise meanings of the "code words"-the triplets of nu­
cleotides-were revealed. Although protein synthesis is complicated, the 
code was found to be universal. With only minor variations of "dialect," 
the same code appears in all living forms: microbial, plant, and animal. 
This fact has profound implications for understanding the interrelation­
ship of living matter and the evolutionary history of life on our planet. 
Large areas of research on cells were soon clarified by this intellectual 
revolution. Simple bacteria could be understood more readily; human 
cells (or "eukaryotic" cells, i.e., cells with nuclei) are far more difficult 
because cells in higher forms of life-including humans -have so much 
more DNA than bacteria. The power of genetic studies was still so 
limited in the early r 970s that further detailed analysis of DNA in higher 
forms seemed remote. It was at this juncture that critically needed tech­
niques were developed. 
Molecular biology and biochemistry are on the frontiers of exciting 
new horizons. For example, slight differences in DNA sequences (called 
DNA polymorphisms) can be used to analyze and map the human chro­
mosome. Such maps will lead, in turn, to deeper knowledge of many 
diseases-from genetic disorders to cancer and aging. 
These molecular, biochemical perspectives also will pave the way 
toward better understanding of the brain and nervous system, building 
the next stages of advanced agricultural production, and fathoming the 
causes of a broad array of diseases for which there is presently no effective 
approach to prevention or cure. Yet the accomplishment of this funda­
mental research-and the innovations that will be based upon it-will 
depend both on expansion of the tools in hand and on invention of new 
concepts and techniques. 
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Scientific Leadership for New Initiatives 
In planning research initiatives and carefully selecting the leaders for 
new laboratories, the University has three goals. First, to sustain the 
University's mission of fundamental research. Second, to seize those 
research opportunities that relate directly to major unsolved human 
problems-fostering the applications that, over the next generation, will 
make a genuine difference to the world. Third, to advance our research 
leadership by adding a new generation of gifted scientists, replacing 
those who have retired recently or who will retire during the next 
decade. 
Biochemical Genetics 
One initiative is a new laboratory headed by Professor Robert G. 
Roeder, who was the James S. McDonnell Professor in Biochemical 
Genetics at Washington University School of Medicine in St. Louis. 
His research activities are directed toward answering key questions 
about the molecular basis of processes such as (a) cell growth and prolif­
eration (e.g., what are the mechanisms in the early development of the 
embryo?); (6) cell differentiation (e.g., what causes a liver cell to be dif­
ferent from a heart cell?); and (c) the infection and transformation of 
mammalian cells by DNA tumor virus (e.g., what are the controls in cells 
that relate to the mechanisms of cancer?). 
The cellular and viral genes that affect these processes are controlled 
in part at the level of transcription ( the first step in the readout of 
genetic information, from DNA to RNA). Dr. Roeder' s work has focused 
largely on an analysis of the biochemical mechanisms that are involved 
in this process for individual genes. 
Dr. Roeder's pioneering work in eukaryotic transcription (i.e., in 
cells with nuclei, as in human cells) began while he was a graduate stu­
dent at the University of Washington. This work led to the first isola-
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tion and characterization of the family of enzymes that directly copy 
genetic information from DNA. On the basis of such fundamental work 
on the eukaryotic transcription machinery, he was awarded the Ameri­
can Chemical Society's Eli Lilly Award in Biological Chemistry in r 977. 
Dr. Roeder's studies complement and allow extension of work on 
gene structure and function already under way in many other labora­
tories at The Rockefeller University and elsewhere. For example, the 
ability to introduce specific mutations into genes (via recombinant DNA
technology) has allowed the delineation of the DNA sequences that are 
important for expression and regulation. However, for most genes, such 
experiments do not readily allow the identification of the regulatory fac­
tors (presumably protein) that interact with and control these genes. 
The approaches in Dr. Roeder' s laboratory allow direct identification of 
such factors and are necessary for fully understanding the mechanisms 
involved in gene control. 
The power and elegance of this approach have been amply demon­
strated for bacterial genes and appear to be equally promising for human 
genes. Ultimately, this line of research should clarify the reasons for 
developmental abnormalities and enhance the explanation of the causes 
of aging and cancer. 
Organic Chemistry and Biochemistry 
The initiative in organic chemistry and biochemistry is a new laboratory 
headed by Professor Emil Thomas Kaiser. Dr.· Kaiser was at the U niver­
sity of Chicago as the Louis Block Professor in the Departments of 
Chemistry and Biochemistry. His research is focused on the actions of 
enzymes. 
In future biomedical research, a major concern will be capitalizing 
on the extensive progress that has been made during the past 40, years in 
understanding the molecular architecture of enzymes-the catalysts that 
make it possible for us to do our daily tasks. The Rockefeller has a long 
tradition in this field; the coming years will see the fruits of past invest-
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ment in such basic research. Significantly, Professor Kaiser came to the 
University with a distinguished record of accomplishment in this spe-
cific area. 
He has applied his early training at Harvard in physico-organic 
chemistry to explaining the mechanisms by which enzymes selectively 
foster certain reactions in the body. For example, he has studied pan­
creatic enzymes, the enzymes concerned with blood pressure, and 
enzymes from the cardiac muscles and from the lung. The "active 
centers" of each of these molecules are being defined chemically, and 
methods of enhancing or reducing their biological "activities" are being 
developed. The work addresses the many diffi�ult problems in under­
standing the relationships between the structure of a substance and the 
substance's function in the body. 
Professor Kaiser has extended such studies to the formation of pro­
teins with new catalytic functions. In these innovative experiments, he 
took an enzyme that facilitated the reaction of water with proteins and 
coupled it to an organic compound that gave the combination a catalytic 
activity toward materials that react with oxygen (such as those found in 
human cells). A new species of catalyst was made; he had achieved an 
artificial chemical hybrid. The preparation of new catalysts in this man­
ner offers promise of application in industry as well as in biology and 
medicine. 
Further, Dr. Kaiser has been exploring the synthesis, from elemen­
tary chemicals, of biologically active components. Proteins are polypep­
tides built from amino acid building blocks, and peptides now can be 
synthesized effectively by laboratory methods devised, in considerable 
part, by Bruce Merrifield at The Rockefeller University. Professor 
Kaiser is making ingenious use of these new synthetic approaches in the 
preparation of new peptides that, for instance, can inhibit enzymes, 
bind lipids (fats), prevent the formation of kidney stones, and prepare 
new hormonal agents. 
These efforts illustrate the enormous opportunities for achieving, 
















Axial projection of the a-helical region of the model peptide showing the relative location 
of the side chains with the segregation of hydrophobic and hydrophilic residues. 
standing of intricate living systems. The University provides a stimulat­
ing context for Dr. Kaiser's efforts, working with both laboratory scien­
tists in related fields and physicians whose patients have diseases that 
must be understood more fully in chemical terms. 
Plant Molecular Biology 
The study of plants has been seminal in the history of biology-both as a 
science and as a technology-from the traditional medicines derived 
from plants through Mendel's revolutionary work on genetics to the 
modern "green revolution." Numerous early and important discoveries 
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Nam-Hai Chua 
at The Rockefeller Institute for Medical Research were based upon plant 
systems and extracts. The University intends to sustain its coherence as 
an institution devoted to the sciences-of-life by maintaining a vigorous 
program, in modern terms, in plant biology. 
Nam-Hai Chua, born in Singapore and educated at Harvard, was 
promoted to full professor in July r 98 r and organized a major new labo­
ratory in plant molecular biology. Professor Chua is a cell and molecular 
biologist who has made contributions to the understanding of photo­
synthesis, chloroplast biogenesis, and plant gene structure and regula­
tion. His special interest is the chloroplast, an organelle in the cells of 
green plants that is important to all life because of its role in photo­
synthesis. Energy from sunlight is trapped in the chloroplast and uti­
lized in the manufacture of complex organic materials, particular! y 
sugar, from simple inorganic substances. 
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Dr. Chua has addressed himself to one of the long-standing puzzles 
in cell biology: how are· needed proteins transported from their sites of 
synthesis elsewhere in the cell to subcellular organelles, such as chloro­
plasts, which have only a limited capacity to produce ,their own 
proteins? 
His current interest is plant gene structure and regulation. He is 
investigating the mechanisms by which the gene that codes for the 
chloroplast enzyme (ribulose diphosphate carboxylase) is differentially 
regulated. This enzyme, found everywhere in green plants, is the most 
abundant protein on earth. It is used for carbon dioxide fixation, the key 
reaction in photosynthesis. It makes up 50% of the soluble protein in 
plants such as soybean, and is present to a lesser extent in other plants 
such as maize and sorghum, which are major food crops. Dr. Chua is 
attempting to identify the gene control regions for this enzyme, which 
would have substantial benefits for agriculture. 
Molecular and Cellular Parasitology 
Because parasitic diseases have not been a significant problem for citi­
zens of the United States-except for travelers and our armed forces sta­
tioned abroad-research on these diseases has never received a high prior­
ity from public or private sponsors. Nonetheless, in global terms, 
parasitic illness ·and death are probably the leading health problem. 
Malaria alone kills a million children, infects about 200 million adults 
each year, and puts about r. 8 billion people at risk. Trypanosomiasis 
and schistosomiasis, among many others, also are critically important 
threats to human health and domesticated animals throughout develop­
ing countries. 
Accordingly, the University has always devoted attention to this 
international problem-from pioneering work early in this century on 
cattle fever and hookworm, as well as on yellow fever and sleeping sick­
ness, to the recent discovery by William Trager that may pave the way 
I I 
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for a vaccine against malaria. Field work has been carried out interna­
tionally, from South America and the Caribbean to India and China, and 
throughout Europe and Africa. 
George A. M. Cross, born in England and educated at Cambridge, 
came to the University from the W ellcome Research Laboratories 
(Kent), where he headed the Department of Immunochemistry, which is 
concerned with parasitic infections. Previously he was a member of the 
biochemical parasitology unit of the Medical Research Council at Cam­
bridge. His new laboratory at The Rockefeller U �iversity will concen­
trate on molecular parasitology. 
Dr. Cross's approach is to study parasitism as a disease process and to 
learn the underlying mechanisms of parasitism. These diseases go 
through specific sets of developmental changes during each life cycle. At 
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each stage, the parasite must express certain genes to facilitate its func­
tion. Decoding these special steps of parasitic action will allow the 
development of very spe�ific agents for the most effective disruption of 
the disease process. Investigating the nature of stage-specific genes, the 
genetic structure and organization, and the expression of parasite-spe­
cific proteins-all should provide much greater insight into the use of 
chemical agents capable of lethal action on specific parasitic stages. It 
may also prove feasible to produce immunological agents capable of in­
terrupting the parasite-host relationship and preventing infection. 
This new line of research has recently been made possible by the 
rapid and revolutionary growth in research technology. To investigate 
the devastating human parasitic diseases at the cellular and subcellular 
levels, and now at the molecular level, requires analysis of parasite gene 
expression. Recombinant DNA technology, monoclonal antibodies, and 
other recent molecular biological advances are eminently suited to this 
work, and Dr. Cross has mastered these new techniques. 
Biology of Skin Diseases 
Skin, the largest organ of the body, has yet to be studied scientifically 
with the scope that it merits. Cancer, aging, disfiguring skin problems 
such as psoriasis and burns, and hazardous environmental' pollutants 
that enter the body through the skin-these suggest the breadth of bio­
logical, medical, and occupational problems related to the skin. Yet 
dermatology rarely has received the attention of first-rank medical inves­
tigators. Accordingly, as the University considered biomedical fields 
that were ripe for attack in our Hospital, this area appeared promising. 
We concluded that there was an unusual opportunity for creative efforts 
on skin disease and identified a distinguished individual who could 
organize a sophisticated approach to research in this area. 
David Martin Carter came to the University in the summer of r 98 r 
from Yale University School of Medicine where he had been Professor of 
Dermatology. After graduating from Dartmouth, he earned an M. D. at 
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D. Martin Carter
Harvard and a Ph.D. in molecular biology at Yale (while serving as a 
Howard Hughes Medical Investigator). In a remarkable way, he com­
bines the necessary laboratory expertise of biochemical analysis with the 
clinical experience required to investigate disabling and lethal skin 
afflictions. 
During the past year he has recruited a group of young collabora­
tors- all with a comparable mix of medical and scientific training. He 
has established strong links with our neighbors, the Memorial Sloan­
Kettering and New York Hospitals, which have many patients in their 
dermatological services. The laboratory's studies of environmental 
impact on skin function deal primarily with damage resulting from 
exposure to chemicals, drugs, and radiation. 
Chromosomes of peripheral blood lymphocytes, differentially stained to show sister chromatids. 
Exchanges between chromatids, promoted by DNA damage, are evident. 
Dr. Carter's new initiatives-ranging from studies of damage to the 
DNA of skin cells to the treatment of various skin disorders-will help to 
build a firm foundation for this domain of medicine. The environment 
at Rockefeller University provides Dr. Carter and his colleagues with 
the opportunity to bridge the barriers that tend to separate laboratory 
investigations from studies of hospitalized and ambulatory patients with 
skin diseases. 
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Neurobiology 
The neurosciences are one of the most dramatic and important frontiers 
for research in the coming decades. Understanding ,how the brain devel­
ops and functions, eliminating psychological (psychiatric) disorders, 
preventing and treating diseases of the brain and nervous system, and 
ascertaining the limits of brain function are the ambitious goals that, for 
the first time, are becoming feasible through the application of modern 
biological tools for research. The University has a long record of accom­
plishment in these fields and continues to assign a high priority to this 
general area. 
Torsten Wiesel, M.D., comes to the University in early 1983 from 
the Harvard Medical School where he has been Robert Winthrop Profes­
sor and Chairman of the Department of Neurobiology. Co-recipient of 
the Nobel Prize in r 98 r, Dr. Wiesel and his colleagues have been pio­
neers in neurophysiology-carrying out pioneering studies of the cells in 
the brain that relate to vision. 
Dr. Wiesel and his group of gifted young collaborators-including 
neuroanatomists, cell biologists, and biochemists- offer remarkable 
complementarity to our ongoing efforts in the neurosciences, from brain 
molecular biology to animal behavior. For example, Dr. Wiesel's cur­
rent research includes "cutting edge" work on the study of methods of 
tissue culture that will permit analysis of single visual cells in isolation. 
Furthermore, the group exploits the �ntire range of modern instru­
ments-from the electron microscope to computer graphics-in trying to 
reveal the elegant networks and ensembles that the brain uses to process 
information. 
N eurochemistry 
As Torsten Wiesel approaches the brain by examining in detail the pro­
cesses of using visual information that comes from outside, the leader of 
another initiative approaches the functions of the brain by exploring the 
chemistry of its inner workings. 
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Paul Greengard comes to the University rn mid- 1983 from Yale 
University Medical School, where he has been Henry Bronson Professor 
of Pharmacology. He is one of the leading neurochemists in the world, 
and has attracted many talented students. 
During the past decade, Dr. Greengard has made a series of discov­
eries about the biochemistry of the brain that have provided a conceptual 
framework for understanding the functioning of the nervous system in 
molecular terms. He demonstrated that certain pharmacological and 
clinical actions (both therapeutic and toxic) of several major classes of 
psychoactive drugs-including common anti psychotic, hallucinogenic, 
and antidepressant drugs-can be explained in terms of selective chemi­
cal actions. This work has provided a practical new approach to the 
development, by pharmaceutical companies, of drugs that act on the 
nervous sys tern. 
Greengard's work has had an impact on many branches of physiol­
ogy, regulatory biology, and medicine. One of his results, formulated 
about ro years ago, provides an explanation of how a single key com­
pound can produce an enormous variety of biological effects. According 
to his widely accepted hypothesis, this chemical compound activates an 
enzyme present in the target tissues, and the specificity of the biological 
effects lies in the nature of the substrate for the enzyme in the target 
tissue. This approach is now being extended to focus on the mechanisms 
of action of environmental toxins-and of alcohol-on the brain. 
The Financial Challenge for Scientific Opportunity 
In formulating a program for New Initiatives, requiring $35 million in 
private support over two years, the University has three components in 
mind. First, $ IO. 5 million would be used as endowment to establish 
professorships for these distinguished members of the faculty, the lead­
ers of the new laboratories. Subject to consultation with donors, chairs 
may be named to honor ·individuals or organizations. 
Second, $ r 4. 5 million would be directed toward the support of out­
standing young investigators- ranging from advanced doctoral students 
through postdoctoral fellows and assistant professors. This fund would 
provide core support for research initiatives by young scientists at a time 
when federal grants for these purposes are declining. Salaries, benefits, 
and technical support will be allocated, at the discretion of the Presi­
dent, for research projects recommended by heads of laboratories. 
Finally, $ r o million would be directed to meeting the start-up costs 
of the seven new laboratories, including the modernization of research 
facilities, the purchase of scientific equipment, and data-handling sys­
tems required for the research. Such capital investments are indispens­
able for modern research, but the federal government is unlike! y to pro­
vide any funding for these purposes. 
An Investment in Talent. The need to endow and name professorships 
grows directly from the University's long-standing tradition and current 
fund-raising goals. The institution's policy is that all tenured members 
of the faculty (the heads of laboratories) are paid entirely from endow­
ment income. Working full-time on a r 2-month basis, these senior sci­
entists are free from the concerns that most faculty members elsewhere 
face in seeking partial grant support for their own salaries. This has fos­
tered greater independence and flexibility, resulting over the years in 
shifts of emphasis that might otherwise not have occurred and that have 
proved to be highly inventive. 
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To sustain this productive tradition against the pressure of rising 
costs, the University must supplement its endowment. Since 197 r, one 
of the highest priority fund-raising objectives has been to add endow­
ment for senior faculty, and a number of grants have been received for 
this purpose. During the next few years, with the renewal of several sci­
entific fields on the campus, it will be even more important to assure the 
stability of support for our scientific leadership. Each chair requires $ r. 5 
million to endow; the capital is invested and a portion of the annual 
income is used to preserve the purchasing power of the endowment. 
The Laboratory and Technology of Science. Typically, a major new labora­
tory requires a substantial investment in start-up costs. Upgrading a 
laboratory-even space that has been used recently by active investiga­
tors- usually means extensive renovation to meet the special needs of the 
new group. Far from a routine "remodeling," the task is to design a 
research facility in a specialized fashion, meeting sophisticated standards 
for research. Changes also are mandated by governmental regulations on 
biological and chemical work in a safe environment. Typically, renova­
tion costs are not less than $ r oo per net square foot, and a major labora­
tory usually requires about 6, oqo net square feet of space. Therefore, the 
total cost of renovation for one laboratory is at least $600,000. 
In addition, purchases of new and costly scientific equipment are 
often required. For example, major instruments (such as a nuclear mag­
netic resonance spectrometer or an electron microscope-each costing 
around $ 3 5 o, ooo) are crucial to the research effort. In many cases, par­
ticular! y during the past decade, even distinguished investigators have 
been unable to purchase new instruments with federal funding. Com­
puting and related data collection are also essential for nearly all 
research, and federal support for computers continues to be extremely 
scarce. New equipment for a laboratory usually requires not less than 
$500,000 and can be as much as$ r ,000,000. 
Assuring Flexibility and Investigative Freedom. Although leading scientists 
continue to be able to attract government funding for their programs, 
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some "core support" for the laboratory must be provided to ensure the 
flexibility needed for exploratory studies. Such core financing may be 
used as a revolving fund to support parts of the salaries of postdoctoral 
fellows and younger faculty who are pursuing pilot studies, most of 
which lead, in time, to federal grants. Also, core support frequently 
covers the replacement of major parts for scientific instruments and 
other emergencies that simply cannot be budgeted or anticipated in 
either federal grants or the University's tight fiscal planning. Require­
ments for core support vary widely from lab to lab and from year to year. 
Usually, that support would be not less than $200,000 per year and 
might reach $ 3 5 o, ooo per year for a large laboratory. Such a laboratory 
usually receives three times that level of funding from federal grants. 
Thus, private support permits great leverage in allowing new ideas to be 
pursued by providing start-up costs and by buffering shifts in availabil­
ity of government funds. 
Summary 
The capital costs associated with the establishment of seven laboratories 
under the University's New Initiatives Program are as follows: 
Professorships. Endow and name distinguished profes-
sorships for scientists who will lead new laboratories 
(seven at $ r . 5 million) 
Young Investigators and Fund for New Initiatives. Sup­
port flexible funding for young investigators and new 
projects; assist in core support of new laboratories for 
five years 
Research Equipment and Facilities. Partial support for 
purchase of scientific. equipment and upgrading 
research facilities required to start new laboratories 
Total 
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$ r o. 5 million 
$ 14. 5 million 
$ ro million 
$ 35 million 
March 1983 
